CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-27 | Jafar Michael M. | Grant or award | +45,000 | 219,851 | ||
| 2021-01-25 | Jafar Michael M. | Sale | −2,699 | $7.46 | $20K | 174,851 |
| 2020-10-28 | Jafar Michael M. | Grant or award | +48,550 | 177,550 | ||
| 2020-10-28 | Jafar Michael M. | Grant or award · Stock Option (Right to Buy) | +79,350 | 79,350 | ||
| 2020-05-13 | Jafar Michael M. Chief Marketing Officer | Grant or award | +40,000 | 129,000 | ||
| 2020-01-23 | Jafar Michael M. Chief Marketing Officer | Grant or award | +26,000 | 89,000 | ||
| 2020-01-23 | Jafar Michael M. Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2019-01-23 | Jafar Michael M. Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2018-09-14 | Jafar Michael M. Chief Marketing Officer | Purchase | +12,800 | $20.83 | $267K | 63,000 |
| 2018-06-18 | Jafar Michael M. Chief Marketing Officer | Grant or award | +50,000 | 50,200 | ||
| 2018-06-18 | Jafar Michael M. Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 |
Page 1 of 1 · 11 trades